CytoMed Therapeutics GDTC Cash Flow Statement (2020-2026)

NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

CytoMed Therapeutics Quarterly Cash Flow Statement

Periods 11 quarters
Latest Jun 2026

CytoMed Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 11 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating Activities
Other non-cash itemsOther Non-Cash -0.11M0.00M
Investing Activities
Change in Acquisitions & DivestmentsChange Acquisitions -4.07M-2.10M-0.35M0.21M
Additional items
Ending Cash Balance 0.67M1.86M1.80M1.18M1.17M4.72M6.64M3.46M3.69M1.63M1.62M

CytoMed Therapeutics Cash Flow Statement API

Pull CytoMed Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GDTC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY